Vaccination of melanoma patients with peptide-or tumorlysate-pulsed dendritic cells

FO Nestle, S Alijagic, M Gilliet, Y Sun, S Grabbe… - Nature medicine, 1998 - nature.com
… by culturing bone marrow or peripheral blood cells in the … stem cell factor, and FLT3 ligand"".
Here we report for the first time on the vaccination of 16 melanoma patients with peptides or …

Phase I dendritic cell p53 peptide vaccine for head and neck cancer

PJ Schuler, M Harasymczuk, C Visus, A DeLeo… - Clinical Cancer …, 2014 - AACR
… of adjuvant p53 peptide-loaded dendritic cell (DC) based adjuvant vaccination for patients
with … vaccine for these patients. With the recent US Food and Drug Administration approval of …

Peptide and dendritic cell vaccines

CL Slingluff Jr, VH Engelhard, S Ferrone - Clinical cancer research, 2006 - AACR
… ; some have used peptide(s) pulsed on dendritic cells. Many of … cell responses can be
generated by vaccination with peptide … that peptide vaccines do not work, that cancer vaccines in …

The use of dendritic cells for peptide-based vaccination in cancer immunotherapy

ML Salem - Cancer vaccines: methods and protocols, 2014 - Springer
… T-cell responses but with limited effects even if the peptide is co-… to cancer-induced dysfunction
in dendritic cells (DC), which … Therefore, DC-based peptide delivery of tumor antigen is …

Enhancement of tumor outgrowth through CTL tolerization after peptide vaccination is avoided by peptide presentation on dendritic cells

REM Toes, EIH van der Voort… - The Journal of …, 1998 - journals.aai.org
… a peptide that readily induces specific CTL tolerance when administered sc in adjuvants. In
this study, we show that peptide-loaded dendritic cells (… of synthetic peptide delivery cause …

Dendritic cells as carriers for a cytotoxic T-lymphocyte epitope–based peptide vaccine in protection against a human papillomavirus type 16–induced tumor

MA Ossevoort, MCW Feltkamp… - Journal of …, 1995 - journals.lww.com
… tumor cells (C3 cellsdendritic cells (DC) that efficiently induce primary peptide-specific CTL
responses in vitro, as physiological carriers for the HPV 16 E7(49–57) peptide-based vaccine

In vivo antigen loading and activation of dendritic cells via a liposomal peptide vaccine mediates protective antiviral and anti-tumour immunity

B Ludewig, F Barchiesi, M Pericin, RM Zinkernagel… - Vaccine, 2000 - Elsevier
… Next, we sought to further optimise the liposomal peptide vaccine and to test the ability of
the vaccine to induce protective antiviral immunity. Oligonucleotides containing unmethylated …

[HTML][HTML] Use of cell-penetrating peptides in dendritic cell-based vaccination

S Lim, JH Koo, JM Choi - Immune network, 2016 - synapse.koreamed.org
… is highly synergistic with the cellular characteristics of the dendritic cells (DCs), … vaccine with
peptide-pulsed dendritic cells generated in vitro from CD34(+) hematopoietic progenitor cells

[HTML][HTML] Adjuvant-free peptide vaccine targeting Clec9a on dendritic cells can induce robust antitumor immune response through Syk/IL-21 axis

S Gou, S Wang, W Liu, G Chen, D Zhang, J Du… - Theranostics, 2021 - ncbi.nlm.nih.gov
… CBP-12 vaccine. Finally, we assessed the effects of the CBP-12 conjugated peptide vaccine
combined with radiotherapy. Results: Here, we developed CBP-12 as a vaccine carrier that …

Targeting dendritic cells in lymph node with an antigen peptide-based nanovaccine for cancer immunotherapy

Y Qian, H Jin, S Qiao, Y Dai, C Huang, L Lu, Q Luo… - Biomaterials, 2016 - Elsevier
peptide-based subunit vaccine formulations for the direct delivery of tumor antigen peptides
(Aps) to dendritic cells … , so their role as potential vaccine targets has been largely overlooked…